Horizon Discovery, ATCC Sign Distribution Deal for Cell Lines | GenomeWeb

NEW YORK (GenomeWeb News) – Horizon Discover today said it has signed a licensing and distribution deal with the American Type Culture Collection for certain sets of panels of X-Man isogenic cell lines.

ATCC will provide to its academic and not-for-profit customers certain Horizon products as part of, or in conjunction with, ATCC's Tumor Cell Panels. The deal is for non-commercial use only and excludes distribution in Japan or distribution of X-Man isogenic cell lines in isolation.

Financial and other terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.